This inventor holds 1 USPTO granted patent. Top assignee: Bayer Corporation. Active years: 2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2002
Title: Innovations in Nasal Drug Delivery by Margaret Caudle
Introduction
Margaret Caudle is an accomplished inventor based in Alameda, CA. He has made significant contributions to the field of pharmaceutical sciences, particularly in the area of nasal drug delivery systems. His innovative work focuses on improving the efficacy and safety of drug administration through the nasal route.
Latest Patents
Margaret Caudle holds a patent for "Compositions for nasal drug delivery, methods of making same, and methods of removing residual solvent from pharmaceutical preparations." This invention relates to pharmaceutical compositions designed for delivering drugs intended to reside in the nose. It specifically addresses antiviral agents that utilize the human major rhinovirus receptor, also known as intercellular adhesion molecule-1 (ICAM-1). The patent also outlines methods for creating these nasal drug compositions and an improved process for removing residual solvents from pharmaceutical matrices.
Career Highlights
Margaret Caudle is currently associated with Bayer Corporation, where he continues to advance his research in pharmaceutical formulations. His work has been instrumental in developing new methods that enhance drug delivery systems, making them more effective for patients.
Collaborations
Throughout his career, Margaret has collaborated with notable colleagues, including Rajiv Nayar and Wei Wang. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the pharmaceutical industry.
Conclusion
Margaret Caudle's contributions to nasal drug delivery represent a significant advancement in pharmaceutical technology. His innovative approaches and dedication to improving drug administration methods continue to impact the field positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
